Aprea Therapeutics, Inc.Aprea Therapeutics, Inc.Aprea Therapeutics, Inc.

Aprea Therapeutics, Inc.

No trades
See on Supercharts

Price target

15.670.000.00%
The 3 analysts offering 1 year price forecasts for APRE have a max estimate of — and a min estimate of —.

Analyst rating

Based on 3 analysts giving stock ratings to APRE in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


APRE EPS for the last quarter is −0.64 USD despite the estimation of −0.72 USD. In the next quarter EPS is expected to reach −0.66 USD. Track more of Aprea Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Aprea Therapeutics, Inc. revenue is expected to reach ‪225.00 K‬ USD. Check out Aprea Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, APRE price target is 15.67 USD with a max estimate of 20.00 USD and a min estimate of 11.00 USD. Check if this forecast comes true in a year, meanwhile watch Aprea Therapeutics, Inc. stock price chart and keep track of the current situation with APRE news and stock market news.